AC Immune (ACIU) News Today → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free ACIU Stock Alerts $2.29 -0.08 (-3.38%) (As of 05:12 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAC Immune (ACIU) Set to Announce Earnings on Fridayamericanbankingnews.com - April 25 at 5:08 AMAC Immune SA (ACIU)finance.yahoo.com - April 18 at 5:53 PMWe Think AC Immune (NASDAQ:ACIU) Can Afford To Drive Business Growthfinance.yahoo.com - April 11 at 8:28 AMAC Immune S.A.wsj.com - March 20 at 5:09 PMHC Wainwright Reaffirms Buy Rating for AC Immune (NASDAQ:ACIU)marketbeat.com - March 18 at 3:09 PMBuy Rating for AC Immune SA on Promising Alzheimer’s Vaccine Trial Design and Potential Accelerated Approvalmarkets.businessinsider.com - March 15 at 11:11 PMFurther weakness as AC Immune (NASDAQ:ACIU) drops 12% this week, taking three-year losses to 58%finance.yahoo.com - March 15 at 8:10 AMACIU Mar 2024 2.500 putfinance.yahoo.com - March 14 at 8:41 PMAC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Updateglobenewswire.com - March 14 at 7:00 AMAC Immune (ACIU) to Release Quarterly Earnings on Mondaymarketbeat.com - March 10 at 7:41 AMLeerink Partnrs Comments on AC Immune SA's Q1 2024 Earnings (NASDAQ:ACIU)marketbeat.com - March 8 at 6:35 AMAC Immune SA: AC Immune Announces Upcoming Presentations at AD/PD 2024finanznachrichten.de - February 22 at 2:31 PMAC Immune Announces Upcoming Presentations at AD/PD™ 2024finance.yahoo.com - February 22 at 9:30 AMAC Immune Announces Upcoming Presentations at AD/PD™ 2024globenewswire.com - February 22 at 7:00 AM5 Little-Known Penny Stocks With Massive Upside Potentialinsidermonkey.com - February 21 at 12:04 PMACIU May 2024 2.500 callfinance.yahoo.com - February 20 at 12:05 AMACIU Aug 2024 2.500 callfinance.yahoo.com - February 20 at 12:05 AMShort Interest in AC Immune SA (NASDAQ:ACIU) Decreases By 14.1%marketbeat.com - February 14 at 3:58 AMAC Immune Ltd (ACIU)investing.com - February 13 at 2:58 PMBuy Rating Affirmed for AC Immune SA Amid Promising Immunotherapy Program Developmentsmarkets.businessinsider.com - February 1 at 2:32 PMDown -35.7% in 4 Weeks, Here's Why AC Immune (ACIU) Looks Ripe for a Turnaroundfinance.yahoo.com - January 30 at 1:17 PMAC Immune SA: AC Immune to Regain Global Rights to Crenezumab and Semorinemabfinanznachrichten.de - January 22 at 10:56 AMAC Immune to Regain Global Rights to Crenezumab and Semorinemabfinance.yahoo.com - January 22 at 10:56 AMAC Immune (ACIU) is a Great Momentum Stock: Should You Buy?finance.yahoo.com - January 18 at 2:43 PM5 Small-Cap Stocks to Play the January Effectfinance.yahoo.com - January 8 at 12:03 PMAC Immune issues updates on Phase 2 studies, cash runwaymsn.com - January 3 at 4:05 PMAC Immune (ACIU) Upgraded to Buy: Here's Whyfinance.yahoo.com - January 3 at 4:05 PMAC Immune Progress Update on Phase 2 Active Immunotherapy Clinical Pipeline for Alzheimer's and Parkinson diseasesfinance.yahoo.com - January 3 at 9:13 AMAC Immune Alzheimer's drug advanced into Phase 2b testingmsn.com - December 15 at 4:02 PMAC Immune’s Targeted Anti-pTau Active Immunotherapy for Alzheimer’s Disease Advances into Phase 2b Trialfinance.yahoo.com - December 15 at 10:39 AMAC Immune Announces Pricing of Underwritten Offering of Common Sharesfinance.yahoo.com - December 15 at 10:39 AMAC Immune SA's (NASDAQ:ACIU) top owners are private equity firms with 37% stake, while 25% is held by individual investorsfinance.yahoo.com - December 13 at 7:29 AMAlzheimer's Disease Space Evolves in 2023: Stocks in Focusfinance.yahoo.com - December 11 at 1:42 PMIs it a Good Idea to Invest in AC Immune (ACIU) Stock Now?finance.yahoo.com - December 5 at 10:00 AMAC Immune Strengthens Management, Appoints Madiha Derouazi as CSO and Christopher Roberts as CFOfinance.yahoo.com - December 1 at 9:38 AMFOCUS-Researchers return to Alzheimer's vaccines, buoyed by recent drug successfinance.yahoo.com - November 20 at 10:30 AMAC Immune SA ACIUmorningstar.com - November 17 at 1:43 PMAre Medical Stocks Lagging AC Immune (ACIU) This Year?finance.yahoo.com - November 9 at 1:55 PMAC Immune to Present at the Jefferies 2023 London Healthcare Conferencefinance.yahoo.com - November 7 at 8:15 AMAC Immune Reports Third Quarter 2023 Financial Results and Provides a Corporate Updatefinance.yahoo.com - November 3 at 10:32 AMAC Immune to Host KOL Webinar on Amyloid Plaque PET Imaging in Alzheimer’s Disease as a Surrogate of Clinical Efficacy on November 9, 2023finance.yahoo.com - November 2 at 7:58 AMAC Immune Clinical Data Published in Nature Communications Show Alpha-Synuclein PET Tracer ACI-12589 Has Potential as Neurodegenerative Disease Diagnosticfinance.yahoo.com - October 27 at 8:25 AMIs AC Immune (ACIU) Stock Outpacing Its Medical Peers This Year?finance.yahoo.com - October 24 at 11:42 AMNeoGenomics (NEO) Soars 8.9%: Is Further Upside Left in the Stock?finance.yahoo.com - October 18 at 10:27 AMAC Immune Announces Upcoming Presentations at the 16th CTAD Conferencefinance.yahoo.com - October 17 at 8:02 AMFurther weakness as AC Immune (NASDAQ:ACIU) drops 14% this week, taking five-year losses to 69%finance.yahoo.com - October 6 at 12:40 PMAC Immune to Present at the Jefferies 2023 CNS & Neuro Summit in October 2023finance.yahoo.com - October 5 at 10:14 AMCitigroup Inc. Takes $2.04 Million Position in AC Immune SA (NASDAQ:ACIU)marketbeat.com - September 7 at 4:28 AMAre Options Traders Betting on a Big Move in AC Immune (ACIU) Stock?finance.yahoo.com - September 5 at 4:54 PMAC Immune (ACIU) Surges 43% in the Past 3 Months: Here's Whyfinance.yahoo.com - September 5 at 4:54 PM Get AC Immune News Delivered to You Automatically Sign up to receive the latest news and ratings for ACIU and its competitors with MarketBeat's FREE daily newsletter. Email Address What is the 72-Hour Profit Surge? (Ad)One of the most overlooked opportunities in the stock market is the 72-Hour Profit Surge... A short period of time where we can bet on a stock that is ALREADY “winning.” Let me give you a perfect example of how the Surge worked with Ross Stores. Back on November 16th, a little move was made that sent their stock soaring… The next day, my system would have alerted me that Ross Stores had entered the 72-Hour Profit Surge… Click here now to get all the details. ACIU Media Mentions By Week ACIU Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ACIU News Sentiment▼0.980.41▲Average Medical News Sentiment ACIU News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ACIU Articles This Week▼41▲ACIU Articles Average Week Get AC Immune News Delivered to You Automatically Sign up to receive the latest news and ratings for ACIU and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: 2seventy bio News Today 23andMe News Today Aldeyra Therapeutics News Today Conduit Pharmaceuticals News Today Verastem News Today Ovid Therapeutics News Today Puma Biotechnology News Today Acrivon Therapeutics News Today XBiotech News Today Xeris Biopharma News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ACIU) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsYour Money is Not SafeAmerican AlternativeThe World's First "$20 Trillion Drug?"Behind the MarketsThe only accurate crypto trading system I know …Weiss RatingsFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AC Immune SA Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
